Krill oil and TAG, VLDL: a pilot study | Lipids Health Dis

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Krill oil supplementation appears to be beneficial as it decreases cardiovascular disease risk parameters through its effects on plasma a triacylglycerol (TAGs), lipoprotein particles, fatty acid profile, redox status and possibly inflammation. 


Study Design

  • A 28 days intervention study assessing effect-parameters of dietary supplementation with krill oil (832.5 mg EPA and DHA per day) in 17 healthy volunteers (18-36 years).
  • Plasma lipids, lipoprotein particle sizes, fatty acid composition in plasma and red blood cells (RBCs), plasma cytokines, antioxidant capacity, acylcarntines, carnitine, choline, betaine, and trimethylamine-N-oxide (TMAO) were measured before and after supplementation.


Key Results

  • Plasma TAG and large very-low density lipoprotein & chylomicron particle concentrations decreased after participants took krill oil for 28 days 
  • A significant reduction in the TAG/HDL cholesterol resulted.
  • Krill oil supplementation also decreased n-6/n-3 polyunsaturated fatty acids (PUFA) ratio both in plasma and RBCs, due to the increase of EPA, DHA and docosapentaenoic acid and reduced amount of arachidonic acid (AA).
  • Krill oil intake increased the antioxidant capacity, double bond index and the fatty acid anti-inflammatory index.

Why This is Important
  • Supplementing with krill oil may help prevent the development of a number of risk factors linked to cardiovascular disease.